$RARE news

The latest RARE stock news: headlines, filings, AI summaries and sentiment for $RARE, updated around the clock.

• Ultragenyx Reports Q3 2026 Revenue Growth and Improved Net Loss Motley Fool · November 4, 2026, 15:09 UTC
• Ultragenyx Pharmaceutical Inc. - 10-Q Filing SEC EDGAR · November 4, 2026, 11:01 UTC
• Ultragenyx Outlines 2027 Profitability Strategy Following Pipeline Adjustments Seeking Alpha · November 4, 2026, 05:46 UTC
• Ultragenyx Pharmaceutical Reports Q3 2026 Earnings Miss on EPS and Revenue Seeking Alpha · November 3, 2026, 21:14 UTC
• Ultragenyx Pharmaceutical Inc. - 8-K Filing SEC EDGAR · November 3, 2026, 21:07 UTC
• Ultragenyx Receives Conditional UK Marketing Authorization for Dojolvi Seeking Alpha · October 30, 2026, 15:46 UTC
• FDA Issues Draft Guidance to Accelerate Personalized Gene Therapy Development Seeking Alpha · October 29, 2026, 19:52 UTC
• Ultragenyx Pharmaceutical Inc. - 8-K Filing SEC EDGAR · October 19, 2026, 13:01 UTC
• Ultragenyx Pharmaceutical Inc. - 8-K Filing SEC EDGAR · October 14, 2026, 13:01 UTC
• Ultragenyx to Sell FDA Priority Review Voucher for $210 Million Seeking Alpha · October 7, 2026, 14:09 UTC
• Ultragenyx Pharmaceutical Inc. - 8-K Filing SEC EDGAR · October 7, 2026, 13:01 UTC
• FDA Approves Fayuvi for Sanfilippo Syndrome, Impact on Ultragenyx's Profitability Target Yahoo Finance · September 22, 2026, 10:18 UTC
• Ultragenyx Pharmaceutical Inc. - 8-K Filing SEC EDGAR · September 17, 2026, 19:56 UTC
• Investor Alert: Pomerantz Law Firm Investigates Claims Against Ultragenyx Pharmaceutical Inc. PR Newswire · September 17, 2026, 14:00 UTC
• Ultragenyx Shares Drop After Phase 3 Trial for Apazunersen Fails to Meet Key Endpoints Yahoo Finance · September 3, 2026, 11:00 UTC
• Stocks Making Major Moves Midday: Tesla Surges Ahead of Cybercab Launch; Snowflake Soars on Strong Earnings CNBC · September 3, 2026, 17:18 UTC
• Ultragenyx Stock Falls Over 46% Following Trial Setback Seeking Alpha · September 3, 2026, 15:31 UTC
• Ultragenyx Stock Plummets After Phase 3 Trial Failure for Angelman Syndrome Treatment Yahoo Finance · September 3, 2026, 13:04 UTC
• Broadcom Upgraded by Macquarie; Ultragenyx Downgraded Following Failed Trial Yahoo Finance · September 3, 2026, 13:31 UTC
• Stocks Making Major Premarket Moves: Snowflake Surges Amid Strong Earnings CNBC · September 3, 2026, 11:35 UTC
• Ultragenyx Reports Phase 3 Trial Failure for Apazunersen in Angelman Syndrome Seeking Alpha · September 3, 2026, 05:55 UTC
• Ultragenyx Pharmaceutical Inc. - 8-K Filing SEC EDGAR · September 2, 2026, 20:05 UTC
• Ultragenyx Pharmaceutical Inc. - 8-K Filing SEC EDGAR · August 19, 2026, 21:25 UTC
• Institutional Confidence in GTX-102 Boosts Outlook for Ultragenyx Pharmaceutical (RARE) Yahoo Finance · June 5, 2026, 15:55 UTC
• Krensavage Asset Management Buys $5.4M in Ultragenyx as Shares Drop 30% Year-to-Date Yahoo Finance · May 30, 2026, 17:56 UTC
• Krensavage Asset Management Buys $5.4M in Ultragenyx as Shares Drop 30% Year-to-Date Motley Fool · May 30, 2026, 17:36 UTC
• Ultragenyx Pharmaceutical Inc. - 8-K Filing SEC EDGAR · May 18, 2026, 18:16 UTC
• Rare Disease Families Gain Tools for Drug Development Through Ultragenyx Bootcamps CNBC · May 7, 2026, 10:30 UTC
• FDA Accepts BLA for Ultragenyx's Gene Therapy for Sanfilippo Syndrome Yahoo Finance · April 19, 2026, 15:43 UTC